Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Poznan
Clinical trial register · Poland

Clinical Trials in Poznan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 1315 Krakow 882 Poznan 705 Gdansk 657 Lodz 619
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca67 Merck Sharp & Dohme LLC43 Poznan University of Medical Sciences35 Janssen Research & Development, LLC27 Bristol-Myers Squibb23
Site location
Warsaw1315 Krakow882 Poznan705 Gdansk657 Lodz619
All 264 locations
Target enrolment
to

Trials with a site in Poznan

705 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Active, closed
Regeneron Pharmaceuticals
Phase 3
1,546
Siedlce, Gdansk, Słupsk, Poznan, Warsaw
2022-07-14
Active, closed
Daiichi Sankyo
Phase 3
586
Bialystok, Lublin, Poznan
2022-07-08
Active, closed
Biohaven Pharmaceuticals, Inc.
Phase 3
269
Gdansk, Poznan, Warsaw, Wroclaw
2022-07-06
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
529
Bialystok, Krakow, Lublin, Nadarzyn, Olsztyn, Poznan, Torun, Warsaw
2022-06-30
Active, closed
Corcept Therapeutics
Phase 3
381
Gdynia, Poznan, Siedlce
2022-06-29
Active, closed
Celgene
Phase 3
939
Bialystok, Krakow, Nowy Sącz, Poznan, Warsaw, Wałbrzych
2022-06-23
Recruiting
BioNTech SE
Phase 1
320
Gdansk, Olsztyn, Poznan, Warsaw
2022-06-17
By invitation
Biogen
Phase 3
864
Bialystok, Bydgoszcz, Bytom, Krakow, Malbork, Poznan, Warsaw
2022-06-10
Active, closed
THIO Sequenced With Cemiplimab in Advanced NSCLC
NCT05208944Carcinoma, Non-Small-Cell Lung
DrugsThiotepa·Cemiplimab
Maia Biotechnology
Phase 2
227
Oświęcim, Bydgoszcz, Krakow, Lodz, Lublin, Poznan, Rzeszów, Skorzewo
2022-06-08
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
312
Otwock, Poznan
2022-05-25
Active, closed
Shanghai Henlius Biotech
Phase 3
511
Poznan, Warsaw
2022-05-17
Active, closed
IO Biotech
Phase 3
407
Warsaw, Poznan
2022-05-17
Active, closed
AstraZeneca
Phase 3
644
Bialystok, Bydgoszcz, Lodz, Poznan, Warsaw, Wroclaw
2022-05-16
Active, closed
Pierre Fabre Medicament
Phase 3
815
Gliwice, Konin, Krakow, Poznan, Skórzewo, Warsaw, Wroclaw
2022-05-02
Recruiting
The Greater Poland Cancer Centre
Not applicable
100
Poznan
2022-05-01
Recruiting
SK Life Science, Inc.
Phase 3
252
Poznan, Krakow
2022-04-28
Active, closed
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
154
Poznan, Warszawa, Bydgoszcz, Wroclaw, Warsaw, Bialystok, Bytom
2022-03-29
Active, closed
Pfizer
Phase 3
854
Skórzewo, Katowice, Gdansk, Poznan, Warsaw, Wroclaw
2022-03-25
Recruiting
AbbVie
Phase 3
768
Poznan, Warsaw, Rzeszów, Olsztyn, Lodz
2022-03-25
Active, closed
Merck Sharp & Dohme LLC
Phase 3
460
Konin, Poznan, Siedlce, Warsaw, Przemyśl, Prabuty, Bystra
2022-03-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Konin, Poznan, Bydgoszcz, Torun, Tarnów, Siedlce, Warsaw, Przemyśl
2022-03-15
By invitation
Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions
NCT05305612Mitral Regurgitation, Atrial Fibrillation, Anticoagulation
National Institute of Cardiology, Warsaw, Poland
Phase 4
410
Gdansk, Katowice, Lublin, Poznan, Warsaw
2022-03-13
Active, closed
Sanofi
Phase 3
122
Poznan, Wroclaw, Rzeszów
2022-03-11
Active, closed
BeOne Medicines
Phase 3
799
Bydgoszcz, Gdansk, Katowice, Krakow, Poznan, Torun, Warsaw
2022-03-10
Recruiting
Takeda
Observational
70
Wroclaw, Poznan, Krakow, Lublin, Tomaszow Mazowiecki, Warsaw, Gdansk, Katowice
2022-03-08
Active, closed
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT05243550Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder
UroGen Pharma Ltd.
Phase 3
240
Gliwice, Krakow, Poznan, Wieliszew
2022-03-01
Recruiting
Pfizer
Phase 3
640
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Katowice
2022-02-28
Active, closed
AstraZeneca
Phase 3
390
Poznan, Warsaw
2022-02-21
Active, closed
AstraZeneca
Phase 3
363
Lodz, Olsztyn, Opole, Poznan, Rzeszów
2022-02-15
Active, closed
AstraZeneca
Phase 3
1,051
Bydgoszcz, Gdansk, Koszalin, Poznan, Siedlce, Tomaszów Mazowiecki, Warsaw
2022-02-07
Active, closed
Merck Sharp & Dohme LLC
Phase 3
280
Poznan, Lublin, Siedlce, Warsaw, Bialystok, Gliwice, Kielce
2022-02-03
Active, closed
Immunic AG
Phase 3
1,100
Katowice, Lublin, Plewiska, Poznan, Warsaw, Zabrze
2022-01-12
Active, closed
Ascendis Pharma Oncology Division A/S
Phase 1/2
320
Krakow, Poznan, Warsaw
2022-01-11
Not yet open
Medical University of Gdansk
Phase 2
126
Poznan, Wroclaw, Warsaw, Opole, Gdansk, Gliwice
2022-01-01
Recruiting
Merck Sharp & Dohme LLC
Phase 1
830
Poznan, Warsaw, Gdansk, Koszalin
2021-12-17
Active, closed
Novartis Pharmaceuticals
Phase 3
1,000
Wroclaw, Bydgoszcz, Kielce, Lodz, Lublin, Piotrkow Trybunalski, Poznan, Rzeszów
2021-12-16
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
2021-12-14
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Poznan, Krakow, Warsaw, Gdansk
2021-12-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
643
Poznan, Warsaw, Bialystok, Gdansk, Gliwice, Kielce
2021-12-13
Recruiting
UCB Biopharma SRL
Phase 3
350
Bydgoszcz, Gdansk, Krakow, Lublin, Nowa Sól, Poznan, Świdnik
2021-12-07
Active, closed
Abivax S.A.
Phase 2
203
Krakow, Lublin, Oświęcim, Piotrkow Trybunalski, Poznan, Tarnów, Warsaw, Wroclaw
2021-12-03
Active, closed
Hoffmann-La Roche
Phase 3
660
Gda?sk, Krakow, Olsztyn, Otwock, Poznan, Warsaw
2021-11-18
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Bydgoszcz, Gdansk, Gdynia, Olsztyn, Poznan, Warsaw
2021-11-17
Active, closed
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291Coronary Artery Disease, Coronary Artery Stenosis
Fondazione Ricerca e Innovazione Cardiovascolare ETS
Not applicable
1,820
Lublin, Poznan
2021-11-16
Active, closed
Cullinan Therapeutics Inc.
Phase 1
440
Józefów, Poznan, Warsaw
2021-10-29
Active, closed
AstraZeneca
Phase 3
148
Gdansk, Gdynia, Krakow, Otwock, Poznan
2021-10-28
Active, closed
Hoffmann-La Roche
Phase 3
303
Bydgoszcz, Poznan, Warsaw, Wroc?aw
2021-10-26
Recruiting
Hoffmann-La Roche
Phase 1
542
Gdansk, Krakow, Poznan, Warsaw
2021-10-22
Active, closed
AbbVie
Phase 1
520
Poznan, Warsaw, Przemyśl, Olsztyn
2021-10-13
Active, closed
Beeline Medicines Corporation
Phase 2
248
Warsaw, Poznan, Wroclaw
2021-10-11
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Gdansk, Lodz, Poznan, Warsaw
2021-10-05
Recruiting
Pfizer
Phase 3
893
Bydgoszcz, Gdansk, Katowice, Poznan, Skorzewo, Warsaw, Wroclaw
2021-10-04
Active, closed
Nuvation Bio Inc.
Phase 2
217
Lodz, Poznan, Torun
2021-09-01
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Bydgoszcz, Gdynia, Gliwice, Grudziądz, Krakow, Lodz, Lublin, Poznan
2021-08-27
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Gdansk, Gliwice, Lublin, Poznan, Warsaw, Wroclaw
2021-08-19
Active, closed
Inventiva Pharma
Phase 3
1,000
Poznan, Wroclaw, Warsaw, Gdynia, Częstochowa, Katowice, Mysłowice, Gdansk
2021-08-19
Active, closed
Hoffmann-La Roche
Phase 1
119
Grudzi?dz, Poznan, Szczecin, Zabrze
2021-08-11
Recruiting
University Medicine Greifswald
Observational
3,000
Bialystok, Bydgoszcz, Katowice, Olsztyn, Poznan, Warsaw
2021-08-06
Active, closed
Boston Scientific Corporation
Phase 4
544
Krakow, Poznan, Warsaw
2021-08-02
By invitation
UCB Biopharma SRL
Phase 3
760
Bialystok, Bydgoszcz, Katowice, Krakow, Lublin, Poznan, Warsaw, Wroclaw
2021-07-27
Active, closed
Pericardial Access With ViaOne Device
NCT05006157Pericardial Access
CardioVia
Not applicable
10
Poznan, Warsaw
2021-07-10
Active, closed
AstraZeneca
Phase 3
315
Bydgoszcz, Gdynia, Koszalin, Lodz, Poznan, Rzeszów, Tomaszów Mazowiecki, Warsaw
2021-06-30
Active, closed
GlaxoSmithKline
Phase 3
40
Katowice, Krakow, Olsztyn, Poznan, Rzeszów, Siedlce, Szczecin, Warsaw
2021-06-28
Recruiting
Penumbra Inc.
Observational
1,500
Krakow, Otwock, Poznan, Warsaw
2021-06-25
Active, closed
Biogen
Phase 3
548
Bialystok, Bydgoszcz, Bytom, Krakow, Lublin, Malbork, Nowa Sól, Poznan
2021-05-25
Active, closed
Bristol-Myers Squibb
Phase 3
681
Biała Podlaska, Bydgoszcz, Gdansk, Krakow, Poznan, Warsaw
2021-05-21
Active, closed
The SELUTION DeNovo Study
NCT04859985Coronary Artery Disease
M.A. Med Alliance S.A.
Not applicable
3,326
Poznan, Rzeszów
2021-05-15
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Bialystok, Gda?sk, Gliwice, Krakow, Poznan, Warsaw
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 3
761
Krakow, Poznan, Warsaw, Wroclaw
2021-05-03
Recruiting
Ipsen
Phase 1/2
240
Gdansk, Katowice, Krakow, Lodz, Oświęcim, Poznan, Sandomierz, Warsaw
2021-04-29
Recruiting
Pfizer
Phase 3
600
Katowice, Krakow, Poznan, Wroclaw
2021-04-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Poznan, Siedlce, Warsaw, Przemyśl, Wrocław, Koszalin
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Konin, Poznan, Bydgoszcz, Radom, Warsaw, Koszalin
2021-04-14
Recruiting
Wielkopolskie Centrum Pulmonologii i Torakochirurgii
Not applicable
200
Poznan
2021-04-08
Recruiting
Boston Scientific Corporation
Observational
5,000
Poznan
2021-03-29
Active, closed
Hoffmann-La Roche
Phase 3
751
Bydgoszcz, Gdansk, Kielce, Krakow, Lodz, Oświęcim, Plewiska, Poznan
2021-03-24
Active, closed
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
496
Gdynia, Grudziądz, Kobylniki, Koszalin, Krakow, Poznan, Warsaw, Wroclaw
2021-03-18
Recruiting
UCB Biopharma SRL
Phase 3
70
Kielce, Krakow, Poznan
2021-03-11
Active, closed
Merck Sharp & Dohme LLC
Phase 3
747
Poznan, Bydgoszcz, Krakow, Warsaw
2021-02-25
Active, closed
Celgene
Phase 3
313
Gdansk, Krakow, Lodz, Poznan, Wałbrzych, Wroclaw
2021-02-25
Active, closed
AstraZeneca
Phase 2
31
Bydgoszcz, Olsztyn, Poznan
2021-02-23
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Gdansk, Gliwice, Poznan, Warsaw, Wroclaw
2021-02-01
Active, closed
AstraZeneca
Phase 3
1,371
Gdynia, Konin, Koszalin, Lodz, Lublin, Olsztyn, Poznan
2021-01-28
Recruiting
Pfizer
Phase 3
2,100
Wroclaw, Katowice, Krakow, Poznan, Szczecin
2021-01-15
Active, closed
Pfizer
Phase 3
257
Krakow, Poznan, Warsaw
2021-01-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
990
Poznan, Siedlce, Warsaw, Bialystok, Gliwice, Olsztyn, Kielce
2021-01-10
Active, closed
Goat Infant Formula Feeding and Eczema (the GIraFFE Study)
NCT04599946Dermatitis, Atopic, Eczema, Infantile, Infant Development, Child Development
Dairy Goat Co-operative (N.Z.) Limited
Not applicable
2,132
Olsztyn, Poznan, Rzeszów, Warsaw
2021-01-08
Recruiting
Secukinumab Open Label Roll-over Extension Protocol
NCT04638647Autoimmunity, Inflammation
DrugSecukinumab
Novartis Pharmaceuticals
Phase 4
1,000
Krakow, Wroclaw, Warsaw, Bialystok, Bydgoszcz, Poznan, Sochaczew, Torun
2020-12-22
Active, closed
Daiichi Sankyo
Phase 3
605
Bialystok, Gdynia, Lublin, Olsztyn, Poznan, Prabuty, Słupsk, Warsaw
2020-12-21
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Poznan, Szczecin
2020-12-21
Active, closed
Neurocrine Biosciences
Phase 3
182
Krakow, Poznan, Warsaw
2020-12-16
Recruiting
FS222 First in Human Study in Patients With Advanced Malignancies
NCT04740424Advanced Cancer, Metastatic Cancer
invoX Pharma Limited
Phase 1
260
Poznan, Krakow
2020-12-14
Active, closed
AMEND-CRT: Mechanical Dyssynchrony as Selection Criterion for CRT
NCT04225520Left Ventricular Dyssynchrony, Heart Failure, Cardiomyopathy, Dilated, Cardiac Remodeling, Ventricular
Universitaire Ziekenhuizen KU Leuven
Not applicable
500
Poznan, Warsaw, Zabrze
2020-12-10
Active, closed
GlaxoSmithKline
Phase 2/3
758
Bydgoszcz, Gdynia, Lodz, Olsztyn, Piła, Poznan
2020-12-08
Active, closed
Daiichi Sankyo
Phase 3
1,600
Poznan, Opole, Gdansk, Lodz, Warsaw
2020-12-04
Recruiting
Mirati Therapeutics Inc.
Phase 2/3
626
Gdansk, Kielce, Krakow, Lublin, Olsztyn, Otwock, Poznan, Skorzewo
2020-12-02
Active, closed
AstraZeneca
Phase 3
957
Bialystok, Gdansk, Krakow, Lodz, Poznan, Warsaw
2020-11-17
Recruiting
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
NCT04688190Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification
Universitätsklinikum Hamburg-Eppendorf
Observational
1,000
Poznan, Warsaw
2020-11-01
Active, closed
Exelixis
Phase 3
575
Otwock, Bydgoszcz, Lodz, Poznan
2020-10-19
Active, closed
Myasthenia Gravis Inebilizumab Trial
NCT04524273Myasthenia Gravis
DrugInebilizumab
Amgen
Phase 3
238
Katowice, Krakow, Poznan, Warsaw
2020-10-15
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bydgoszcz, Gdansk, Gdynia, Olsztyn, Poznan, Warsaw
2020-10-13
Active, closed
AstraZeneca
Phase 3
370
Bialystok, Bydgoszcz, Poznan
2020-10-02
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bydgoszcz, Gdansk, Gdynia, Olsztyn, Poznan, Warsaw
2020-09-30
Active, closed
AbbVie
Phase 3
330
Piła, Poznan, Krakow, Lublin, Warsaw, Gdansk, Katowice, Lodz
2020-08-31
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Gdansk, Poznan, Warsaw
2020-08-25
Active, closed
A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing Tumors
NCT04482309Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer, Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
DrugTrastuzumab deruxtecan
AstraZeneca
Phase 2
477
Bydgoszcz, Gdansk, Krakow, Poznan, Warsaw
2020-08-18
Active, closed
Hoffmann-La Roche
Phase 3
271
Lublin, Poznan, Warsaw, Wroclaw
2020-08-10
Active, closed
AstraZeneca
Phase 3
185
Bialystok, Grzepnica, Lublin, Olsztyn, Poznan
2020-08-04
Active, closed
AstraZeneca
Phase 3
1,012
Bydgoszcz, Gdansk, Koszalin, Lodz, Olsztyn, Poznan, Rzeszów, Torun
2020-07-13
Active, closed
Sun Pharmaceutical Industries Limited
Phase 3
296
Bialystok, Lublin, Poznan, Warsaw
2020-07-01
Active, closed
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
530
Gdansk, Koszalin, Krakow, Mysłowice, Poznan, Skórzewo, Warsaw
2020-06-29
Active, closed
Eli Lilly and Company
Phase 3
996
Poznan, Bydgoszcz, Krakow, Wadowice, Swidnica, Wroclaw, Lublin, Zamość
2020-06-22
Active, closed
Eli Lilly and Company
Phase 3
1,736
Poznan, Bydgoszcz, Krakow, Ścinawa, Wroclaw, Lublin, Warsaw, Warsawawa
2020-06-19
Recruiting
Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracranial Bleeding.
NCT04298723Intracranial Hemorrhages, Atrial Fibrillation (AF), Atrial Flutter
Jena University Hospital
Not applicable
530
Poznan, Bielsko-Biala, Katowice
2020-06-16
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Gdansk, Gliwice, Poznan, Warsaw
2020-06-12
Active, closed
GlaxoSmithKline
Phase 3
494
Chorzów, Krakow, Lodz, Lublin, Nowy Sącz, Poznan, Warsaw
2020-05-07
Active, closed
KANDO Research
Not applicable
286
Krakow, Poznan
2020-05-05
Active, closed
Amgen
Phase 3
145
Lublin, Poznan
2020-02-26
Active, closed
Actelion
Phase 3
138
Gdansk, Krakow, Poznan, Warsaw, Wroclaw, Zabrze
2020-01-16
Active, closed
Sperm Selection Strategies and Male-Factor Phenotypes in ICSI
NCT07825584Assisted Reproductive Technology, Assisted Reproductive Technology Outcomes
Center for Reproductive Medicine Bocian
Observational
12,561
Poznan, Lublin, Warsaw, Rzeszów, Bialystok, Gdansk, Katowice, Szczecin
2020-01-02
Active, closed
Pfizer
Phase 3
1,068
Gliwice, Grudziądz, Mysłowice, Piotrkow Trybunalski, Poznan, Skierniewice, Warsaw, Wroclaw
2019-12-30
Active, closed
GlaxoSmithKline
Phase 1
118
Lublin, Poznan
2019-12-18
Active, closed
CStone Pharmaceuticals
Phase 3
534
Poznan, Wroclaw, Bydgoszcz, Warsaw
2019-12-13
Recruiting
Trifecta-Kidney cfDNA-MMDx Study
NCT04239703Kidney Transplant Rejection
University of Alberta
Observational
300
Bialystok, Bydgoszcz, Gdansk, Katowice, Poznan, Szczecin, Warsaw, Wroclaw
2019-12-01
Active, closed
TG Therapeutics, Inc.
Phase 3
1,100
Katowice, Krakow, Lodz, Olsztyn, Poznan, Warsaw, Zabrze
2019-11-18
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Poznan, Krakow, Warsaw, Lublin, Wroclaw
2019-11-13
Active, closed
Novartis Pharmaceuticals
Phase 1
120
Gdansk, Poznan
2019-10-30
Active, closed
Bristol-Myers Squibb
Phase 3
790
Poznan, Gdansk, Warsaw
2019-10-28
Active, closed
Novo Nordisk A/S
Phase 3
134
Poznan, Krakow, Warsaw, Lublin, Wroclaw
2019-10-21
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Krakow, Poznan
2019-10-03
By invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
NCT03683186PAH, Pulmonary Hypertension, Pulmonary Arterial Hypertension, Hypertension
United Therapeutics
Phase 3
1,000
Bialystok, Krakow, Otwock, Poznan, Wroclaw
2019-09-23
Active, closed
Applied Therapeutics, Inc.
Phase 3
675
Wroclaw, Bialystok, Krakow, Lodz, Poznan, Radom, Rzeszów
2019-09-20
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
NCT04104776Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant
DrugsTulmimetostat·Enzalutamide
Novartis Pharmaceuticals
Phase 1/2
300
Gdansk, Krakow, Lodz, Poznan, Warsaw
2019-09-18
Active, closed
Pfizer
Phase 3
896
Poznan, Wroclaw, Będzin, Bialystok, Gdansk, Gdynia, Jelenia Góra, Lodz
2019-09-05
Recruiting
Bristol-Myers Squibb
Phase 2
1,500
Bydgoszcz, Olsztyn, Biała Podlaska, Gdansk, Krakow, Lodz, Lublin, Poznan
2019-08-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
595
Poznan, Bydgoszcz, Tarnów, Wroclaw, Otwock, Warsaw, Bialystok, Słupsk
2019-07-24
Active, closed
Amgen
Phase 3
457
Bydgoszcz, Poznan, Warsaw, Wroclaw
2019-07-19
Active, closed
Tesaro, Inc.
Phase 3
785
Bialystok, Gdynia, Lodz, Olsztyn, Poznan, Szczecin, Warsaw
2019-07-18
Active, closed
Exelixis
Phase 3
855
Biała Podlaska, Bydgoszcz, Gdansk, Otwock, Poznan
2019-06-25
Active, closed
AstraZeneca
Phase 3
923
Bydgoszcz, Konin, Poznan, Racibórz, Radom, Tomaszów Mazowiecki, Warsaw, Wroclaw
2019-06-25
Active, closed
Bristol-Myers Squibb
Phase 3
437
Biała Podlaska, Bydgoszcz, Bytom, Gdansk, Poznan, Warsaw
2019-06-21
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Gliwice, Krakow, Poznan, Warsaw
2019-06-04
Recruiting
HighLife SAS
Not applicable
120
Gdansk, Katowice, Poznan, Warsaw
2019-05-28
Active, closed
Novo Nordisk A/S
Phase 3
1,500
Bialystok, Bydgoszcz, Chorzów, Gdansk, Katowice, Krakow, Lodz, Poznan
2019-05-08
Active, closed
AstraZeneca
Phase 3
810
Gdansk, Lodz, Olsztyn, Poznan, Warsaw, Wroclaw
2019-04-16
Active, closed
Javelin Medical
Not applicable
100
Poznan
2019-04-15
Active, closed
Madrigal Pharmaceuticals, Inc.
Phase 3
1,759
Częstochowa, Gdansk, Gdynia, Katowice, Lodz, Poznan, Skórzewo, Warsaw
2019-03-28
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Bialystok, Gdansk, Konin, Lodz, Olsztyn, Opole, Poznan, Tomaszów Mazowiecki
2019-03-21
Active, closed
Celgene
Phase 3
363
Lodz, Gdansk, Lubin, Poznan, Rzwszow, Słupsk, Wałbrzych, Wroclaw
2019-01-02
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Bydgoszcz, Gdansk, Glogow Wielkopolski, Katowice, Kielce, Lodz, Poznan, Rzeszów
2018-12-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,397
Poznan, Torun, Krakow, Tarnów, Wroclaw, Siedlce, Warsaw, Przemyśl
2018-12-24
Active, closed
AstraZeneca
Phase 2
401
Bialystok, Lodz, Poznan, Prabuty
2018-12-21
Active, closed
AstraZeneca
Phase 3
407
Bialystok, Gdansk, Poznan, Tomaszów Mazowiecki, Warsaw
2018-11-27
Active, closed
AstraZeneca
Phase 3
1,063
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Ostrołęka, Poznan
2018-11-16
Active, closed
The Greater Poland Cancer Centre
Not applicable
40
Poznan
2018-10-11
Active, closed
AbbVie
Phase 2
270
Poznan, Warsaw, Przemyśl, Szczecin, Lodz
2018-10-10
Active, closed
Exelixis
Phase 3
187
Poznan, Warsaw, Gliwice
2018-10-05
Active, closed
AstraZeneca
Phase 3
730
Gdansk, Olsztyn, Poznan, Tomaszów Mazowiecki, Warsaw, Wroclaw
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Bialystok, Gdansk, Grudziądz, Koszalin, Krakow, Olsztyn, Poznan, Radom
2018-09-27
Active, closed
Merck Sharp & Dohme LLC
Phase 3
976
Poznan, Bydgoszcz, Krakow, Warsaw, Rzeszów, Gdansk, Bielsko-Biala, Katowice
2018-09-12
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Konin, Poznan, Bydgoszcz, Krakow, Warsaw, Opole, Bialystok, Gdansk
2018-08-21
Active, closed
Hoffmann-La Roche
Phase 3
257
Gda?sk, Krakow, Olsztyn, Poznan
2018-08-16
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Brzozów, Gdynia, Krakow, Poznan
2018-07-17
Recruiting
Polish Multicenter PERTs PE Outcomes Registry
NCT04879069Pulmonary Embolism With Acute Cor Pulmonale
Poznan University of Medical Sciences
Observational
10,000
Poznan
2018-06-01
Active, closed
Biotronik SE & Co. KG
Observational
3,030
Lodz, Poznan, Warsaw
2018-05-14
Active, closed
AstraZeneca
Phase 3
1,018
Bialystok, Gdansk, Grudziądz, Koszalin, Piotrkow Trybunalski, Poznan, Warsaw, Wroclaw
2018-05-14
Active, closed
pharmaand GmbH
Phase 3
1,097
Warsaw, Bialystok, Gdynia, Lublin, Poznan, Szczecin
2018-05-14
Active, closed
GlaxoSmithKline
Phase 2
237
Brzozów, Chorzów, Gdansk, Krakow, Lublin, Opole, Poznan
2018-05-03
Active, closed
Merck Sharp & Dohme LLC
Phase 3
797
Poznan, Bydgoszcz, Bystra, Wroclaw, Prabuty, Lodz
2018-04-24
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Poznan, Warsaw
2018-04-11
Active, closed
AbbVie
Phase 3
1,336
Poznan, Torun, Wroclaw, Lublin, Warsaw, Rzeszów, Chojnice, Tychy
2018-04-09
Recruiting
Mineral Status in Pregnant Women
NCT03598361Pregnancy; Disorder, Blood
Poznan University of Life Sciences
Observational
550
Poznan
2018-03-20
Active, closed
AstraZeneca
Phase 2
273
Dąbrowa Górnicza, Gdansk, Gdynia, Grzepnica, Krakow, Lodz, Olsztyn, Poznan
2018-03-07
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Poznan
2018-01-01
Active, closed
Sanofi
Phase 3
475
Poznan, Lodz, Warsaw, Gdansk
2017-12-07
Active, closed
Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410Oropharyngeal Cancer, Supraglottic Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
112
Poznan
2017-11-27
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Gda?sk, Olsztyn, Poznan, Warsaw
2017-09-22
Active, closed
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
NCT03212404Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Small Cell, Malignant Mesothelioma, Advanced
Checkpoint Therapeutics, Inc.
Phase 1
272
Krakow, Lodz, Lublin, Poznan, Warsaw
2017-09-20
Active, closed
Eli Lilly and Company
Phase 3
5,637
Konin, Poznan, Wroclaw, Lublin, Warsaw, Opole, Gdansk, Gdynia
2017-07-12
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
Gdansk, Gliwice, Poznan, Warsaw
2017-05-03
Active, closed
Pfizer
Phase 3
296
Gdansk, Poznan, Szczecin, Warsaw
2017-04-27
Recruiting
Turning Point Therapeutics, Inc.
Phase 1/2
500
Gdansk, Lublin, Poznan, Szczecin, Warsaw
2017-03-07
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Bialystok, Bystra, Lublin, Olsztyn, Poznan, Warsaw
2016-09-13
Active, closed
University of Chicago
Phase 3
180
Poznan
2016-04-26
Active, closed
Geron Corporation
Phase 2/3
289
Wroclaw, Słupsk, Poznan, Olsztyn, Piła
2016-01-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,503
Bialystok, Bydgoszcz, Gdynia, Gliwice, Kielce, Lodz, Olsztyn, Poznan
2015-11-19
Active, closed
AstraZeneca
Phase 3
953
Bydgoszcz, Kielce, Krakow, Lodz, Mrozy, Olsztyn, Poznan, Warsaw
2015-11-03
Active, closed
AstraZeneca
Phase 3
682
Krakow, Lodz, Otwock, Poznan, Racibórz, Warsaw, Wieliszew
2015-10-21
Active, closed
Medtronic
Observational
3,100
Poznan, Zabrze
2015-07
Active, closed
Exelixis
Phase 4
247
Poznan, Gliwice
2015-02-25
Recruiting
Poznan University of Medical Sciences
Observational
300
Poznan
2014-11
Active, closed
AstraZeneca
Phase 1
344
Gdansk, Krakow, Olsztyn, Poznan, Warsaw
2014-08-05
Active, closed
AstraZeneca
Phase 3
1,837
Gdansk, Grzepnica, Lodz, Olsztyn, Poznan, Warsaw
2014-04-22
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,207
Bialystok, Bydgoszcz, Gdansk, Kutno, Lodz, Poznan, Szczecin, Torun
2013-10-14
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Lodz, Lublin, Poznan, Wroclaw
2013-07-26
Active, closed
MedImmune LLC
Phase 2
571
Gdansk, Poznan, Szczecin, Warsaw
2013-05-17
Recruiting
St. Anna Kinderkrebsforschung
Phase 2/3
1,800
Bydgoszcz, Krakow, Lublin, Poznan, Wroclaw
2013-04
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Gdansk, Katowice, Krakow, Poznan, Warsaw
2012-07
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Poznan, Warsaw, Zabrze
2012-01
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Bialystok, Gdansk, Lublin, Poznan, Rzeszów, Szczecin
2008-12-09
Active, closed
Genentech, Inc.
Phase 2
378
Gdansk, Kielce, Otwock, Poznan, Rybnik, Warsaw
2008-10-16
Recruiting
University Hospital, Gasthuisberg
Observational
5,000
Krakow, Poznan
2005-08
Active, closed
AstraZeneca
Phase 3
736
Bialystok, Lodz, Poznan
2005-02-13
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Bialystok, Chorzów, Gdansk, Lodz, Poznan, Szczecin, Warsaw, Wroclaw
1994-01
Recruiting
Medtronic
Observational
20,000
Poznan, Warsaw, Zabrze
1983-01
Rows per page Showing 501–705 of 705
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/poznan?page=2

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 705 of those studies with a site in Poznan.

How many clinical trials are recruiting in Poznan?

357 of the 705 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 23 have not yet opened recruitment, 306 are active but closed to new participants, and 19 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.